1999 Abstract: 3485 INTERLEUKIN-11: A CYTOKINE OR AN INTESTINAL GROWTH FACTOR?
Abstracts
|
Our laboratory has been interested in studying the effects of certain growth factors on small intestine function. This study was designed to examine the effect of systemic administration of Interleukin-11(IL-11), a 19kD cytokine expressed in multiple tissues, on mucosal function and mass in the normal small intestine and intestine following massive small bowel resection (MSBR). Methods: Twenty young adult male Sprague-Dawley rats were used in this study. Ten rats underwent an 80% small bowel resection and end-to-end jejunoileal anastomosis. Seven days following resection, all rats had placement of a jugular venous catheter connected to a subcutaneously placed osmotic minipump. The rats were divided into 4 groups based on the contents of the osmotic minipump: Group 1 (n=5), normal rat receiving 0.1% bovine serum albumin (BSA); Group 2 (n=5), normal rat receiving IL-11 at 750mg/kg/day; Group 3 (n=5), short bowel rat receiving 0.1% BSA; and Group 4 (n=5), short bowel rat receiving IL-11 at 750mg/kg/day. Following a 14-day infusion period, [14C] galactose and [14C] glycine absorption were measured using a closed-recirculation technique. Mucosal DNA and protein content were also determined for each group. Statistical analysis was performed by ANOVA and expressed as meanąSEM. Results: Conclusions: This study demonstrates that IL-11 as a cytokine also acts as a growth factor by enhancing mucosal absorptive function (carbohydrate, 35% increase) and mass (76% increase) in the normal intestine and intestine following MSBR (increase in carbohydrate, 73%; amino acid, 112%; and DNA content, 97%). IL-11 may prove to have an important role clinically in patients with inadequate intestinal function. Acknowledgement: Interleukin-11 was provided by the Genetics Institute, Cambridge, Massachusetts. Copyright 1996 - 1999, SSAT, Inc. |